RPG Life Sciences Ltd. (RPGLIFE): RPG Life Sciences Share Price Rises 9.14% to Rs 2,998; Market Cap at Rs 4,576.35 Cr
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
RPG Life Sciences Share Price is in focus after the stock rose 9.14% today to Rs 2,998, up Rs 251.05 from the previous close of Rs 2,746.95. The company’s market capitalisation stands at Rs 4,576.35 Cr, placing the move in a clearly measurable market-capitalisation context. Today’s trading range started at Rs 2,733.55 and ended at the day’s high of Rs 2,998, so the session finished at the top of the day’s range.
The move makes RPG Life Sciences Share Price one of the notable stock market stories in the healthcare space today. Based on the supplied data, the price event is confirmed, while a company-specific catalyst is not established. For readers following RPG Life Sciences Share Price Today, the useful next checks are the valuation metrics, return ratios, sector benchmark and peer context that frame the stock’s current pricing. Univest is tracking the same data set to keep the article factual, searchable and easy to compare with other pharma names.
RPG Life Sciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,998 |
| Previous Close | Rs 2,746.95 |
| Today's Move | Rs 251.05 (+9.14%) |
| Open | Rs 2,733.55 |
| High | Rs 2,998 |
| Low | Rs 2,733.55 |
| Turnover | Rs 1.52 crore |
| Market Capitalisation | Rs 4,576.35 crore |
| Market Cap Category | Small Cap |
RPG Life Sciences Ltd. (RPGLIFE) rose to Rs 2,998 from the previous close of Rs 2,746.95, a move of Rs 251.05 or 9.14%. The stock opened at Rs 2,733.55, reached a high of Rs 2,998, recorded a low of Rs 2,733.55.
RPG Life Sciences Share Price Today shows a clean same-day price rise from Rs 2,746.95 to Rs 2,998, with the stock adding Rs 251.05 or 9.14%. The session opened at Rs 2,733.55, printed a low of Rs 2,733.55 and closed at the day’s high of Rs 2,998. Turnover stood at Rs 1.52 Cr. The supplied numbers confirm the price rise and the intraday finish without establishing a company-specific trigger. For readers scanning RPG Life Sciences Stock News, this is a straightforward market update built on verified trade data rather than interpretation beyond the facts.
RPG Life Sciences Ltd. (RPGLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,576.35 crore |
| P/E Ratio | 39.45x |
| P/B Ratio | 7.14x |
| ROE | 20.28% |
| ROCE | 26.99% |
| EPS | Rs 69.64 |
| Book Value Per Share | Rs 384.61 |
| Dividend Yield | 0.87% |
RPG Life Sciences Ltd. (RPGLIFE) fundamental metrics show P/E 39.45x, P/B 7.14x, ROE 20.28%, ROCE 26.99%. These figures provide context only and are not a buy or sell signal.
RPG Life Sciences Ltd. has a market capitalisation of Rs 4576.35 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.45x, P/B at 7.14x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.28% and ROCE of 26.99%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 69.64, book value per share of Rs 384.61, dividend yield of 0.87%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.75x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.45x |
| Benchmark Median P/E | 31.75x |
| Benchmark Average P/E | 49.54x |
| Benchmark P/E Range | 3.48x to 765.12x |
| Company P/B Ratio | 7.14x |
| Benchmark Median P/B | 3x |
| Company ROE | 20.28% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 26.99% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 4,576.35 crore |
| Benchmark Median Market Cap | Rs 748.47 crore |
RPG Life Sciences Ltd. (RPGLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 39.45x, which is above the benchmark median of 31.75x, a difference of +24.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
RPG Life Sciences Ltd. (RPGLIFE) has a ROE of 20.28%, which is above the benchmark median of 11.7%, a difference of +73.33%. RPG Life Sciences Ltd. (RPGLIFE) has a ROCE of 26.99%, which is above the benchmark median of 13.46%, a difference of +100.52%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,195.77 | 36.58 | 5.12 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,50,389.96 | 84.8 | 14.04 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,966.75 | 87.04 | 21.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,860.07 | 25.66 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.1 | 3.17 | 11.83 | 16 |
RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 39.45x compared with the displayed peer median of 36.58x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.28% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.99% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RPG Life Sciences Ltd. (RPGLIFE) has a market capitalisation of Rs 4,576.35 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching RPG Life Sciences
- RPG Life Sciences Share Price rose 9.14% today to Rs 2,998, with the day’s high also at Rs 2,998.
- The stock closed above the previous close of Rs 2,746.95 by Rs 251.05, which is the exact same-day move.
- Market cap stands at Rs 4,576.35 Cr, giving the rise a clear company-size context.
- P/E is 39.45 and P/B is 7.14, both above the sector medians of 31.75 and 3.
- ROE of 20.28% and ROCE of 26.99% are both above the sector medians in the same industry set.
About RPG Life Sciences
RPG Life Sciences Ltd. operates in the Pharmaceuticals & Drugs industry within Healthcare. The company is part of the listed Indian pharma universe and is tracked through its NSE and BSE share price updates, financial ratios and sector comparison set on Univest. The supplied data does not include a segment-wise revenue split, so the business description here stays limited to the verified industry classification.
For readers using RPG Life Sciences Share Price as a starting point, the relevant company facts are the market capitalisation of Rs 4,576.35 Cr, EPS of Rs 69.64, book value of Rs 384.61 and dividend yield of 0.87%. These figures help frame the company’s earnings base and accounting equity against the day’s share price rise. Univest presents RPG Life Sciences Share Price Today with the same emphasis on verified financial analysis and market update context.
Track RPG Life Sciences Share Price on Univest
Use RPG Life Sciences Ltd. (RPGLIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track RPG Life Sciences Share Price Live on Univest for current price, financial ratios, shareholding pattern, 52-week levels and market insights. The same page also helps users review RPG Life Sciences Stock News, RPG Life Sciences Latest News and RPG Life Sciences Share Price Update in one place. Univest keeps the data flow organised so readers can compare the stock with sector and peer figures quickly.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is RPG Life Sciences Share Price rising today?
Ans. The supplied data confirms a 9.14% rise to Rs 2,998, but it does not establish a company-specific catalyst. The session closed at the day’s high, and turnover stood at Rs 1.52 Cr.
What is RPG Life Sciences Share Price today?
Ans. RPG Life Sciences Share Price today is Rs 2,998. It moved up Rs 251.05 from the previous close of Rs 2,746.95, making it a notable same-day price rise in the healthcare space.
What is the market cap of RPG Life Sciences?
Ans. RPG Life Sciences has a market capitalisation of Rs 4,576.35 Cr. That places the company above the sector median of Rs 748.47 Cr in the supplied same-industry benchmark set. The company operates in the Healthcare sector.
What do RPG Life Sciences valuation ratios show?
Ans. The stock’s P/E is 39.45 and P/B is 7.14. Both sit above the sector medians, while ROE of 20.28% and ROCE of 26.99% are also above the benchmark medians. The company trades at a P/E ratio of 39.45x.
How do RPG Life Sciences earnings metrics look?
Ans. EPS is Rs 69.64 and book value is Rs 384.61 per share. These figures help explain the earnings base and accounting equity behind the current RPG Life Sciences Share Price.
What is the dividend yield of RPG Life Sciences?
Ans. RPG Life Sciences has a dividend yield of 0.87%. That is a historical payout measure linked to the current price, so it should be read alongside earnings, valuation and return ratios.
How does RPG Life Sciences compare with pharma peers?
Ans. In the supplied peer set, RPG Life Sciences is much smaller by market cap than Sun Pharma, Divi’s, Torrent, Zydus and Cipla. Its ROE and ROCE are comparatively strong against several of those peers.
